Raxone is indicated to treat Leber’s hereditary optic neuropathy (LHON), a heritable genetic disease causing blindness. The deal will enable Santhera to launch Raxone in Bulgaria, Croatia, Czech
The company bought full rights to patents, compounds, know-how and collaboration/licence deals from Altermune for an undisclosed amount. Centauri will use the Alphamer technology for drug discovery and
A prescription drug user fee act action date of 16 May 2016 has been assigned, six months after the submission of the sNDA. The sNDA was based on
Bial said it is working with health authorities to understand the causes of this tragic and unfortunate situation. The yet to be named drug, believed to be BIA
The approval follows a positive opinion by the European Medicines Agency’s Committee for Medicinal Products for Human Use. In a phase 3 clinical trial, Benepali showed comparable safety
The drug has now been approved to treat adults with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) inflammatory diseases, which affect the joints and/or spine. The
Isomerase discovers and develops molecules that target peptidyl-prolyl isomerases including cyclophilins. The acquisition intends to further improve the collaboration between the firms and speed up NeuroVive’s research and
Selinexor is the company’s oral selective inhibitor of Nuclear Export (SINE) compound. It binds to and inhibits the nuclear export protein XPO1, resulting in the accumulation of tumor
Imetelstat, discovered by Geron, is a potent and specific inhibitor of telomerase that is administered by intravenous infusion. The clinical trial, also referred to as the IMerge study,
The deal is anticipated to close by the end of this month, earlier than scheduled. Galapagos will receive an upfront payment of $725m, which includes a license fee
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.